anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

204,481-204,540 of 319,975

filter-aware
13
The slide displays 8 individual patient charts tracking three biomarkers over 64 weeks. Two patients (53 and 58) show NA retreatment periods.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
14
Data presented at EASL 2022. Shows longitudinal patient data for patients 42, 43, and 48.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
15
The slide uses a bulleted list to present clinical safety findings.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
16
The slide uses a four-column layout to present key findings from a clinical trial.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
17
The slide uses a timeline-based process diagram to illustrate the clinical trial flow.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit
18
The slide outlines two distinct study arms involving AB-729, VTP-300, and Nivolumab, with a primary focus on safety and reactogenicity.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit
19
The slide details a licensing deal with Qilu Pharmaceutical, including financial terms and partner background.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit
20
The slide uses a three-column layout to highlight key value propositions.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit
21
Includes a line chart for efficacy over time and two bar charts for pharmacokinetic concentrations in plasma vs liver.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit
22
Includes a disclaimer at the bottom regarding an FDA clinical hold.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit
23
The slide uses two distinct chart types (dose-response curve and bar chart) to show efficacy in two different biological assays.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit
24
Arbutus Biopharma | Investor Presentation Deck | 28 slidesArbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit
25
The slide uses a biological map of the coronavirus genome to justify targeting nsp5 and nsp12.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit
26
The slide highlights key therapeutic advantages of the candidate drug.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit
27
Includes a checkmark indicating completion of one milestone.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit
28
Arbutus Biopharma | Investor Presentation Deck | 28 slidesArbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit
01
Slide 1
argenx SE | Results Presentation Deck | 13 slidesargenx SE | Results Presentation Deck | 13 slides · argenx
Conference presentation Investor relations Beat · What Is1 hit
02
argenx SE | Results Presentation Deck | 13 slidesargenx SE | Results Presentation Deck | 13 slides · argenx
Conference presentation Investor relations Beat · What Is1 hit
03
The slide uses a four-circle diagram to represent strategic pillars, flanked by specific business achievements.argenx SE | Results Presentation Deck | 13 slides · argenx
Conference presentation Investor relations Beat · What Is1 hit
04
The slide uses a circular portrait montage to humanize the clinical goals.argenx SE | Results Presentation Deck | 13 slides · argenx
Conference presentation Investor relations Beat · What IsLoop · Aha Moment1 hit
05
The slide uses a timeline-based layout to communicate clinical trial milestones.argenx SE | Results Presentation Deck | 13 slides · argenx
Conference presentation Investor relations Beat · What IsLoop · Aha Moment1 hit
06
The slide uses a visual representation of an antibody to explain the mechanism of action (sweeping antibody, pH/Ca2+ switch, no effector function).argenx SE | Results Presentation Deck | 13 slides · argenx
Conference presentation Investor relations Beat · What Could BeLoop · Aha Moment1 hit
07
Includes a biological mechanism diagram on the left and a clinical trial roadmap on the right.argenx SE | Results Presentation Deck | 13 slides · argenx
Conference presentation Investor relations Beat · What Could Be1 hit
08
The slide uses a bar chart for historical trend and a table for regional performance.argenx SE | Results Presentation Deck | 13 slides · argenx
Conference presentation Investor relations Beat · New Bliss1 hit
09
The slide highlights a significant reduction in operating loss and net loss compared to the prior year period.argenx SE | Results Presentation Deck | 13 slides · argenx
Conference presentation Investor relations Beat · New Bliss1 hit
10
The diagram features the argenx logo at the center, surrounded by five values: Co-Creation, Empowerment, Excellence, Humility, and Innovation.argenx SE | Results Presentation Deck | 13 slides · argenx
Conference presentation Investor relations Beat · New BlissLoop · Why Now1 hit
11
Uses a hub-and-spoke style layout to connect stakeholders to specific strategic initiatives.argenx SE | Results Presentation Deck | 13 slides · argenx
Conference presentation Investor relations Beat · New BlissLoop · Why Now1 hit
12
The slide uses a geographic split between US and Global markets to track regulatory milestones.argenx SE | Results Presentation Deck | 13 slides · argenx
Conference presentation Investor relations Beat · New BlissLoop · Why Now1 hit
13
The slide uses a circular cluster diagram to represent the four pillars surrounding the central vision statement.argenx SE | Results Presentation Deck | 13 slides · argenx
Conference presentation Investor relations Beat · New Bliss1 hit
01
Slide 1
Arrival | Results Presentation Deck | 13 slidesArrival | Results Presentation Deck | 13 slides · Arrival
Conference presentation Investor relations 1 hit
02
Arrival | Results Presentation Deck | 13 slidesArrival | Results Presentation Deck | 13 slides · Arrival
Conference presentation Investor relations 1 hit
03
Arrival | Results Presentation Deck | 13 slidesArrival | Results Presentation Deck | 13 slides · Arrival
Conference presentation Investor relations 1 hit
04
Arrival | Results Presentation Deck | 13 slidesArrival | Results Presentation Deck | 13 slides · Arrival
Conference presentation Investor relations 1 hit
05
Includes a photo of the Delta L Van assembly line in Bicester.Arrival | Results Presentation Deck | 13 slides · Arrival
Conference presentation Investor relations 1 hit
06
Arrival | Results Presentation Deck | 13 slidesArrival | Results Presentation Deck | 13 slides · Arrival
Conference presentation Investor relations 1 hit
07
The slide uses a mix of production metrics and qualitative operational updates.Arrival | Results Presentation Deck | 13 slides · Arrival
Conference presentation Investor relations 1 hit
08
Arrival | Results Presentation Deck | 13 slidesArrival | Results Presentation Deck | 13 slides · Arrival
Conference presentation Investor relations 1 hit
09
Arrival | Results Presentation Deck | 13 slidesArrival | Results Presentation Deck | 13 slides · Arrival
Conference presentation Investor relations 1 hit
10
Arrival | Results Presentation Deck | 13 slidesArrival | Results Presentation Deck | 13 slides · Arrival
Conference presentation Investor relations 1 hit
11
Arrival | Results Presentation Deck | 13 slidesArrival | Results Presentation Deck | 13 slides · Arrival
Conference presentation Investor relations 1 hit
12
Arrival | Results Presentation Deck | 13 slidesArrival | Results Presentation Deck | 13 slides · Arrival
Conference presentation Investor relations 1 hit
13
This appears to be a product reveal or marketing slide showing two variants of a vehicle.Arrival | Results Presentation Deck | 13 slides · Arrival
Conference presentation Investor relations 1 hit
01
Slide 1
Asos | Results Presentation Deck | 36 slidesAsos | Results Presentation Deck | 36 slides · Asos
Conference presentation Investor relations 1 hit
02
Asos | Results Presentation Deck | 36 slidesAsos | Results Presentation Deck | 36 slides · Asos
Conference presentation Investor relations 1 hit
03
The slide uses a list-based structure to highlight progress on the 'Driving Change' agenda.Asos | Results Presentation Deck | 36 slides · Asos
Conference presentation Investor relations 1 hit
04
Asos | Results Presentation Deck | 36 slidesAsos | Results Presentation Deck | 36 slides · Asos
Conference presentation Investor relations 1 hit
05
The slide uses a numbered list format with imagery to represent four key strategic pillars.Asos | Results Presentation Deck | 36 slides · Asos
Conference presentation Investor relations 1 hit
06
The slide uses a structured table-like layout to map strategic initiatives to business outcomes.Asos | Results Presentation Deck | 36 slides · Asos
Conference presentation Investor relations 1 hit
07
Uses a before-after framing to highlight operational improvements.Asos | Results Presentation Deck | 36 slides · Asos
Conference presentation Investor relations 1 hit
08
The slide uses a combination of a combo chart (bar/line) and a process flow diagram to explain the strategic shift.Asos | Results Presentation Deck | 36 slides · Asos
Conference presentation Investor relations 1 hit
09
Asos | Results Presentation Deck | 36 slidesAsos | Results Presentation Deck | 36 slides · Asos
Conference presentation Investor relations 1 hit
10
Asos | Results Presentation Deck | 36 slidesAsos | Results Presentation Deck | 36 slides · Asos
Conference presentation Investor relations 1 hit
11
Uses a three-column process flow (Opportunity -> Focus -> Outcome) to map strategic initiatives to business results.Asos | Results Presentation Deck | 36 slides · Asos
Conference presentation Investor relations 1 hit
12
Uses a before-after framing to highlight realized benefits.Asos | Results Presentation Deck | 36 slides · Asos
Conference presentation Investor relations 1 hit
13
The slide uses a 2x2 grid layout to categorize operational efficiency initiatives.Asos | Results Presentation Deck | 36 slides · Asos
Conference presentation Investor relations 1 hit
14
Asos | Results Presentation Deck | 36 slidesAsos | Results Presentation Deck | 36 slides · Asos
Conference presentation Investor relations 1 hit
15
Uses a process-like flow to map opportunities to focus areas and outcomes.Asos | Results Presentation Deck | 36 slides · Asos
Conference presentation Investor relations 1 hit
16
Uses a before-after framing to highlight strategic financial actions taken.Asos | Results Presentation Deck | 36 slides · Asos
Conference presentation Investor relations 1 hit
17
The slide uses a project-to-result mapping format.Asos | Results Presentation Deck | 36 slides · Asos
Conference presentation Investor relations 1 hit
18
Uses a three-column structure (Opportunity, Immediate focus, Outcome) to map strategic initiatives.Asos | Results Presentation Deck | 36 slides · Asos
Conference presentation Investor relations 1 hit